Placental transfer of the insulin analog glargine in the ex vivo perfused placental cotyledon model

Michal Kovo, Abraham Golan, Julio Wainstein, Zipora Matas, Simon Haroutiunian, Amnon Hoffman

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Objective. The aim was to characterize the transfer of the insulin analog glargine across the placenta using the placental perfusion model. Methods. Placentas were obtained and selected cotyledons were cannulated and dually perfused. Glargine, 50 mU/L (n = 2) and 200 mU/L (n = 1), and a reference marker, antipyrine (50 μg/mL), were added to the maternal circulation. Samples were taken from the maternal and fetal compartments. Results. Glargine was not detected in the fetal compartment. In the maternal compartment, the steady state concentration was 50% lower than the starting concentration. Conclusions. Glargine probably does not cross the human placenta. Reduced maternal steady state concentrations may suggest insulin uptake by the placenta.

Original languageEnglish
Pages (from-to)19-24
Number of pages6
JournalEndocrine Research
Volume36
Issue number1
DOIs
StatePublished - Jan 20 2011
Externally publishedYes

Keywords

  • glargine
  • perfusion model
  • placenta

Fingerprint Dive into the research topics of 'Placental transfer of the insulin analog glargine in the ex vivo perfused placental cotyledon model'. Together they form a unique fingerprint.

  • Cite this